首页|不同剂量米非司酮联合腹腔镜手术治疗子宫肌瘤对患者激素水平的影响研究

不同剂量米非司酮联合腹腔镜手术治疗子宫肌瘤对患者激素水平的影响研究

扫码查看
目的 探究不同剂量米非司酮联合腹腔镜手术治疗子宫肌瘤对其激素水平的影响。方法 选取 100 例子宫肌瘤患者,按照抽签法分为对照组(50 例)和试验组(50 例)。两组均进行腹腔镜手术治疗,对照组在上述基础上采用 25 mg米非司酮治疗,试验组在上述基础上采用 12。5 mg米非司酮治疗。比较两组患者临床疗效、术后恢复状况(阴道流血时间、月经恢复时间、治疗前后子宫体积)、性激素[血清孕酮(P)、卵泡刺激素(FSH)、雌二醇(E2)]、疼痛程度。结果 试验组总有效率为 96。00%,高于对照组的 80。00%(P<0。05)。试验组术后阴道流血时间(13。05±1。45)d、月经恢复时间(33。34±4。05)d均短于对照组的(17。45±2。25)、(49。34±2。38)d(P<0。05);两组治疗后子宫体积均小于本组治疗前,且试验组子宫体积(107。89±8。98)cm3 小于对照组的(124。45±12。47)cm3(P<0。05)。两组治疗后血清孕酮、FSH、E2 水平均低于治疗前,且试验组血清孕酮(8。45±1。21)nmol/L、FSH(14。32±2。47)U/L、E2(130。89±23。32)pmol/L均低于对照组的(11。62±1。29)nmol/L、(18。65±2。56)U/L、(175。46±42。38)pmol/L(P<0。05)。试验组Ⅰ级疼痛占比 74。00%高于对照组的 40。00%,而Ⅱ级和Ⅲ级疼痛占比 20。00%、6。00%低于对照组的40。00%、20。00%(P<0。05)。结论 相较于 25 mg米非司酮,12。5 mg米非司酮联合腹腔镜手术治疗可提高子宫肌瘤的临床疗效,减轻疼痛程度,改善性激素水平,促进患者术后快速恢复。
Study on effects of different doses of mifepristone combined with laparoscopic surgery on hormone levels of patients with uterine fibroids
Objective To explore the effects of different doses of mifepristone combined with laparoscopic surgery on hormone levels of patients with uterine fibroids.Methods A total of 100 patients with uterine fibroids were selected and divided into a control group(50 cases)and an experimental group(50 cases)according to the lottery method.Laparoscopic surgery was performed in both groups.On this basis,the control group was treated with 25 mg mifepristone,and the experimental group was treated with 12.5 mg mifepristone.Comparison was made on clinical efficacy,postoperative recovery status(vaginal bleeding time,menstrual recovery time and uterine volume),sex hormones[serum progesterone(P),follicle stimulating hormone(FSH),estradiol(E2)],and pain degree between the two groups.Results The total effective rate of 96.00%in the experimental group was higher than 80.00%in the control group(P<0.05).In the experimental group,the postoperative vaginal bleeding time was(13.05±1.45)d and the menstrual recovery time was(33.34±4.05)d,which were shorter than(17.45±2.25)and(49.34±2.38)d in the control group(P<0.05).After treatment,the uterine volume in both groups was smaller than that before treatment,and the uterine volume of(107.89±8.98)cm3 in the experimental group was smaller than(124.45±12.47)cm3 in the control group(P<0.05).After treatment,the serum progesterone,FSH,E2 levels in both groups were lower than those before treatment;the experimental group had serum progesterone of(8.45±1.21)nmol/L,FSH of(14.32±2.47)U/L,and E2 of(130.89±23.32)pmol/L,which were lower than(11.62±1.29)nmol/L,(18.65±2.56)U/L,and(175.46±42.38)pmol/L in the control group(P<0.05).The percentage of grade Ⅰ pain in the experimental group was 74.00%,which was higher than 40.00%in the control group;the percentage of grade Ⅱ and Ⅲ pain in the experimental group were 20.00%and 6.00%,which were lower than 40.00%and 20.00%in the control group(P<0.05).Conclusion Compared with 25 mg mifepristone,12.5 mg mifepristone combined with laparoscopic surgery for the treatment of uterine fibroids can improve the clinical efficacy,reduce pain degree,improve sex hormone levels,promote rapid postoperative recovery of patients.

Uterine fibroidsMifepristoneLaparoscopic surgerySex hormone

张婷

展开 >

438300 麻城市人民医院妇产科、病案科

子宫肌瘤 米非司酮 腹腔镜手术 性激素

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(19)